Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone

Kidney International

Volumn 74, Issue 11, 2008, Pages 1403-1409

  Chiga, Motoko ^a   Rai, Tatemitsu ^a   Yang, Sung Sen ^b   Ohta, Akihito ^a   Takizawa, Toichiro ^c   Sasaki, Sei ^a   Uchida, Shinichi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Hypertension; Knock in mouse; NaCl reabsorption; Pseudohypoaldosteronism type II

Indexed keywords

ALDOSTERONE; PHOSPHOTRANSFERASE; PROTEIN KINASE OSR1 SPAK; PROTEIN KINASE WNK1; SODIUM CHLORIDE COTRANSPORTER; SPIRONOLACTONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; ENZYME PHOSPHORYLATION; KIDNEY DISTAL TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOHYPOALDOSTERONISM; SALT INTAKE; SODIUM RESTRICTION;

ALDOSTERONE; ANIMALS; DISEASE MODELS, ANIMAL; MICE; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PSEUDOHYPOALDOSTERONISM; SODIUM CHLORIDE SYMPORTER INHIBITORS; SODIUM CHLORIDE SYMPORTERS; SODIUM CHLORIDE, DIETARY;

EID: 56549094967     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.451     Document Type: Article

References (29)

1. Schambelan M, Sebastian A, Rector Jr FC. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption. Kidney Int 1981; 19: 716-727.
2. Gordon RD. Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate. Hypertension 1986; 8: 93-102.
3. Shimkets RA, Warnock DG, Bositis CM et al. Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994; 79: 407-414.
4. Verissimo F, Jordan P. WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 2001; 20: 5562-5569.
5. Wilson FH, Disse-Nicodeme S, Choate K et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293: 1107-1112.
6. Yang CL, Angell J, Mitchell R et al. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 2003; 111: 1039-1045.
7. Kahle KT, Wilson FH, Leng Q et al. WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion. Nat Genet 2003; 35: 372-376.
8. Wilson FH, Kahle KT, Sabath E et al. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci USA 2003; 100: 680-684.
9. Kahle KT, Rinehart J, Ring A et al. WNK protein kinases modulate cellular Cl- flux by altering the phosphorylation state of the Na-K-Cl and K-Cl cotransporters. Physiology (Bethesda) 2006; 21: 326-335.
10. Yamauchi K, Yang SS, Ohta A et al. Apical localization of renal K channel was not altered in mutant WNK4 transgenic mice. Biochem Biophys Res Commun 2005; 332: 750-755.
11. Yang SS, Yamauchi K, Rai T et al. Regulation of apical localization of the thiazide-sensitive NaCl cotransporter by WNK4 in polarized epithelial cells. Biochem Biophys Res Commun 2005; 330: 410-414.
12. Ohta A, Yang SS, Rai T et al. Overexpression of human WNK1 increases paracellular chloride permeability and phosphorylation of claudin-4 in MDCKII cells. Biochem Biophys Res Commun 2006; 349: 804-808.
13. Yamauchi K, Rai T, Kobayashi K et al. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc Natl Acad Sci USA 2004; 101: 4690-4694.
14. Lalioti MD, Zhang J, Volkman HM et al. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 2006; 38: 1124-1132.
15. Yang SS, Morimoto T, Rai T et al. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab 2007; 5: 331-344.
16. Vitari AC, Deak M, Morrice NA et al. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases. Biochem J 2005; 391: 17-24.
17. Moriguchi T, Urushiyama S, Hisamoto N et al. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J Biol Chem 2005; 280: 42685-42693.
18. O'Reilly M, Marshall E, Macgillivray T et al. Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo. J Am Soc Nephrol 2006; 17: 2402-2413.
19. Kim GH, Masilamani S, Turner R et al. The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci USA 1998; 95: 14552-14557.
20. Leopold JA, Dam A, Maron BA et al. Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med 2007; 13: 189-197.
21. Hirono Y, Yoshimoto T, Suzuki N et al. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local rennin-angiotensin system. Endocrinology 2007; 148: 1688-1696.
22. Yang CL, Zhu X, Ellison DH. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex. J Clin Invest 2007; 117: 3403-3411.
23. Ring AM, Leng Q, Rinehart J et al. An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis. Proc Natl Acad Sci USA 2007; 104: 4025-4029.
24. Ellison DH, Velazquez H, Wright FS. Thiazide-sensitive sodium chloride cotransport in early distal tubule. Am J Physiol 1987; 253: F546-F554.
25. Gagnon KB, England R, Delpire E. Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter. Mol Cell Biol 2006; 26: 689-698.
26. Gagnon KB, England R, Delpire E. Volume sensitivity of cation-Cl-cotransporters is modulated by the interaction of two kinases: Ste20-related proline-alanine-rich kinase and WNK4. Am J Physiol Cell Physiol 2006; 290: C134-C142.
27. Kahle KT, Ring AM, Lifton RP. Molecular Physiology of the WNK Kinases. Annu Rev Physiol 2007; 70: 329-355.
28. McCormick JA, Yang C-L, Ellison DH. WNK kinases and renal sodium transport in health and disease. An integrated view. Hypertension 2008; 51: 588-596.
29. Richardson C, Rafiqi FH, Karlsson HK et al. Activation of the thiazidesensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1. J Cell Sci 2008; 121: 675-684.